- call +1-201-465-4211
- email sales@mrinsights.biz
Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body.
Scope of the Report:
This report focuses on the Injectable Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such as morphine or diacetylmorphine/heroin; roughly two-thirds of which is destroyed in the liver when consumed orally) than oral ingestion would, meaning users get a stronger (yet shorter-acting) effect from the same amount of the drug.
The worldwide market for Injectable Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
AbbVie
F. Hoffmann-La Roche
GlaxoSmithKline
Sanofi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Biologics
Small molecules
Market Segment by Applications, can be divided into
Auto-immune diseases
Hormonal Disorders
Orphan Diseases
Oncology
There are 15 Chapters to deeply display the global Injectable Drugs market.
Chapter 1, to describe Injectable Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Injectable Drugs, with sales, revenue, and price of Injectable Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Injectable Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Injectable Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Injectable Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Injectable Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Biologics
1.2.2 Small molecules
1.3 Market Analysis by Applications
1.3.1 Auto-immune diseases
1.3.2 Hormonal Disorders
1.3.3 Orphan Diseases
1.3.4 Oncology
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Injectable Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 F. Hoffmann-La Roche
2.2.1 Business Overview
2.2.2 Injectable Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 F. Hoffmann-La Roche Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Injectable Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Injectable Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Injectable Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Injectable Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Injectable Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Injectable Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Injectable Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Injectable Drugs Market Analysis by Regions
4.1 Global Injectable Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Injectable Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Injectable Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Injectable Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Injectable Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Injectable Drugs Sales and Growth Rate (2013-2018)
4.5 South America Injectable Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Injectable Drugs Sales and Growth Rate (2013-2018)
5 North America Injectable Drugs by Countries
5.1 North America Injectable Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Injectable Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Injectable Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Injectable Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Injectable Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Injectable Drugs Sales and Growth Rate (2013-2018)
6 Europe Injectable Drugs by Countries
6.1 Europe Injectable Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Injectable Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Injectable Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Injectable Drugs Sales and Growth Rate (2013-2018)
6.3 UK Injectable Drugs Sales and Growth Rate (2013-2018)
6.4 France Injectable Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Injectable Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Injectable Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Injectable Drugs by Countries
7.1 Asia-Pacific Injectable Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Injectable Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Injectable Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Injectable Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Injectable Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Injectable Drugs Sales and Growth Rate (2013-2018)
7.5 India Injectable Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Injectable Drugs Sales and Growth Rate (2013-2018)
8 South America Injectable Drugs by Countries
8.1 South America Injectable Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Injectable Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Injectable Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Injectable Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Injectable Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Injectable Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Injectable Drugs by Countries
9.1 Middle East and Africa Injectable Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Injectable Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Injectable Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Injectable Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Injectable Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Injectable Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Injectable Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Injectable Drugs Sales and Growth Rate (2013-2018)
10 Global Injectable Drugs Market Segment by Type
10.1 Global Injectable Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Injectable Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Injectable Drugs Revenue and Market Share by Type (2013-2018)
10.2 Biologics Sales Growth and Price
10.2.1 Global Biologics Sales Growth (2013-2018)
10.2.2 Global Biologics Price (2013-2018)
10.3 Small molecules Sales Growth and Price
10.3.1 Global Small molecules Sales Growth (2013-2018)
10.3.2 Global Small molecules Price (2013-2018)
11 Global Injectable Drugs Market Segment by Application
11.1 Global Injectable Drugs Sales Market Share by Application (2013-2018)
11.2 Auto-immune diseases Sales Growth (2013-2018)
11.3 Hormonal Disorders Sales Growth (2013-2018)
11.4 Orphan Diseases Sales Growth (2013-2018)
11.5 Oncology Sales Growth (2013-2018)
12 Injectable Drugs Market Forecast (2018-2023)
12.1 Global Injectable Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Injectable Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Injectable Drugs Market Forecast (2018-2023)
12.2.2 Europe Injectable Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Injectable Drugs Market Forecast (2018-2023)
12.2.4 South America Injectable Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Injectable Drugs Market Forecast (2018-2023)
12.3 Injectable Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Injectable Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Injectable Drugs Market Share Forecast by Type (2018-2023)
12.4 Injectable Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Injectable Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Injectable Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Injectable Drugs Picture
Table Product Specifications of Injectable Drugs
Figure Global Sales Market Share of Injectable Drugs by Types in 2017
Table In
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
